"Lynch Syndrome causes a high risk of #colon, uterine, stomach and gastric cancers - these are very preventable with frequent screening or risk reducing surgery. 95% of people with #LynchSyndrome are not aware of their diagnosis. We have a very long way to go." - Heather Hampel

Joan Rush, President, had the opportunity to team up with Heather Tomlinson, PhD , Dir. of Clinical Diagnostics, Promega Corporation to discuss the importance of knowing if you have #LynchSyndrome and MSI tumor testing to guide your cancer treatment.

The Importance of MSI Testing for Lynch Syndrome youtu.be/KR-BITebFk0 via YouTube

Did you watch the Access Health episode this morning?? If you missed it, you can still watch it next Wednesday, 9/30 at 7:30AM (EST/PST) on Lifetime Television. Or watch it NOW on Access Health's Youtube page: youtube.com/watch?v=COtqMh… #LynchSyndrome

Just spoke with a well educated, professional male stage IV #colorectalcancer survivor in the fight since 2/19 treated at an National Cancer Institute cancer center who does not know his biomarkers-lots of work to do...Fight Colorectal Cancer Colorectal Cancer Alliance @GYRIG Colon Cancer Foundation Heather Tomlinson, PhD #research #advocacy

#LynchSyndrome a common inherited genetic cancer causing syndrome passed down through families that significantly increases the risk of colorectal, uterine, & many other cancers compared to the general population.

Meet the new FORCE! We’ve expanded and rebranded to educate and support those with #LynchSyndrome, #BRCA, #ATM, #PALB2, #CHEK2, #PTEN or other inherited mutations. We are here for you. ow.ly/42vc50BK7Pj #1FORCECommunity #HereditaryCancer

Congratulations to Emma Crosbie and neil ryan as their research has led to new NICE guidelines. Now all women diagnosed with #WombCancer will be tested for #LynchSyndrome. Read more from Policy@Manchester below 👇 NIHR Manchester Biomedical Research Centre MFT Research and Innovation Peaches Womb Cancer Trust Team Womb

Join the first installment in this series to learn about MSI as a biomarker. #MSI #oncology #biomaker labroots.com/virtual-event/…

Join Promega and four esteemed speakers on November 5 for Session 1 of our virtual Microsatellite Instability Series. Learn how MSI, a decades-old hereditary cancer test, has become an important pan tumor biomarker for immunotherapeutic response. bit.ly/3ekQeEp

A Microsatellite Instability (MSI) Series Labroots labroots.com/virtual-event/…

Excited to share the results of our collaboration with Johns Hopkins University validating the use of the Promega LMR MSI Analysis System for detecting MSI in several cancer types. promega.com/aboutus/press-…

"Validation of Long Mononucleotide Repeat Markers for Detection of Microsatellite Instability", new #OpenAccess content from Association for Molecular Pathology member author James R. Eshleman and colleagues from Johns Hopkins Medicine and Promega Corporation. jmdjournal.org/article/S1525-…

BioIVT proudly presents our new Scientific Advisory Board members. This prestigious group will provide valuable insights in their fields of ADME-Tox, drug development, cell and gene therapy and diagnostics. Learn how the new SAB will support BioIVT. hubs.ly/Q01gxSG00

Do you have #Lynchsyndrome? See if you qualify to participate in a clinical trial bit.ly/ihavelynch #cancerprevention Northwestern Medicine MD Anderson Cancer Center KU Cancer Center Cleveland Clinic MD The Ohio State University College of Medicine University of Utah Mayo Clinic Dana-Farber University of Michigan University of Arizona @CUSyste National Cancer Institute Lynch Syndrome Intl

This is a great opportunity for those with Lynch Syndrome to participate in a cancer prevention clinical trial! #msiinsiders

MSI by PCR results showing 3 of 5 microsatellites measured in normal tissue on the top and tumor on the bottom. The extra peaks to the left in the tumor indicate that all 3 of these markers are unstable and this tumor is MSI-high. #ColorectalCancerAwarenessMonth

UK National Health Service Rolls out Lynch Syndrome Genetic Testing | ⁦GenomeWeb⁩ precisiononcologynews.com/molecular-diag…